or
forgot password

    • cancer clinical trials in waterbury, CT

    • PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Prostate Cancer
    Aminopterin in Treating Patients With Refractory Leukemia
    Urology Specialists, P.C.
    Waterbury, Connecticut 06708
    Leukemia
    Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Urology Specialists, P.C.
    Waterbury, Connecticut 06708
    Bladder Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Harold Leever Regional Cancer Center
    Waterbury, Connecticut 06708
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Harold Leever Regional Cancer Center
    Waterbury, Connecticut 06708
    Breast Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Medical Oncology and Hematology, PC at Harold Leever Cancer Center
    Waterbury, Connecticut 06708
    Breast Cancer
    Computed Tomography Laser Mammography Breast Imaging Device
    Waterbury Hospital Health Center
    Waterbury, Connecticut
    Breast Cancer
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Medical Oncology and Hematology
    Waterbury, Connecticut 06708
    Breast Cancer
    Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Bladder Cancer
    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Prostate Cancer
    Eflornithine in Treating Patients With Bladder Cancer
    Urology Specialists, P.C.
    Waterbury, Connecticut 06708
    Bladder Cancer
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
    The Harold Lever Regional Cancer Center
    Waterbury, Connecticut 06708
    Melanoma, Neoplasm Metastasis
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Prostatic Neoplasms
    GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
    Medical Oncology and Hematology
    Waterbury, Connecticut 06708
    Colorectal Cancer
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Connecticut Clinical Research
    Waterbury, Connecticut 06708
    Prostate Cancer, Osteoporosis, Fractures
    Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
    Medical Oncology & Hematology
    Waterbury, Connecticut 06708
    Multiple Myeloma
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Chase Medical Research, Llc
    Waterbury, Connecticut 06708
    Atrial Fibrillation, Atrial Flutter
    Assess Cancer in Ovarian Tumors With Biomarkers.
    The GYN Center for Women's Health
    Waterbury, Connecticut 06708
    Ovarian Tumor
    Assessment and Tracking of Long-term Alefacept Safety
    Jeffrey Alter
    Waterbury, Connecticut 06708
    Psoriasis
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Study Facility
    Waterbury, Connecticut 06708
    Hypoactive Sexual Desire Disorder
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Medical Oncology & Hematology, PC
    Waterbury, Connecticut 06708
    Cachexia
    Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC
    Medical Oncology & Hematology
    Waterbury, Connecticut 06708
    Non-Small Cell Lung Cancer
    Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
    Site Reference ID/Investigator# 6627
    Waterbury, Connecticut 06708
    Non-Small Cell Lung Cancer (NSCLC)
    Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Prostate Cancer
    A Study of Degarelix in Patients With Prostate Cancer
    Connecticut Clinical Research Center
    Waterbury, Connecticut 06708-2652
    Prostate Cancer
    Xpress Digital Mammography System Images for Computer Aided Detection Development
    Waterbury Hospital
    Waterbury, Connecticut
    Breast Cancer
    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
    Hematology and Medical Oncology
    Waterbury, Connecticut 06708
    First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Medical Oncology Hematology
    Waterbury, Connecticut 06708
    Locally Recurrent or Metastatic Breast Cancer